Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2020-03-25 | Julia A. Haller, M.D. Director Since: 2019 Age: 65 Board Committees • Science & Technology Committee • Integration Committee ...Julia A. Haller, M.D. received $78,413 total compensation in 2019. |
2021-03-25 | Julia A. Haller, M.D. Director Since: 2019Age: 66 Board Committees • Committee on Directors and Corporate Governance • Science & Technology Committee Other Public BoardsFormer • Celgene Corporation Experience • Ophthalmologist-in-Chief of Wills Eye Hospital in Philadelphia, PA, where she holds the William Tasman, M.D. Endowed Chair (2007-present) • Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Thomas Jefferson University Hospitals (present) • Member of the Johns Hopkins faculty, where she held the Katharine Graham Chair in Ophthalmology (until 2007) • Trained at the Wilmer Eye Institute at Johns Hopkins where she served as the first female Chief Resident Key Skills and Experience • Academia / Non-Profit • Healthcare • Science / Technology / Innovation Other • Director (former President), Association of University Professors of Ophthalmology • Member, National Academy of Medicine • Vice Chair of Board of Trustees, The College of Physicians of Philadelphia • Board of Trustees, Society of HEED Fellows |
2022-03-24 | Experience: • Ophthalmologist-in-Chief of Wills Eye Hospital in Philadelphia, PA, where she holds the William Tasman, M.D. Endowed Chair (2007-present) • Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Thomas Jefferson University Hospitals (present) • Member of the Johns Hopkins faculty, where she held the Katharine Graham Chair in Ophthalmology (until 2007) |
2023-03-23 | Julia A. Haller, M.D. Director Since: 2019 Age: 68 Board Committees • Science & Technology Committee (Chair) • Committee on Directors and Corporate Governance Other Public Company Boards • Opthea Limited • Outlook Therapeutics, Inc. |
2024-03-28 | Julia A. Haller, M.D. Chair of the Science & Technology Committee DIRECTOR SINCE: 2019 AGE: 69 BOARD COMMITTEES Science & Technology Committee (Chair), Committee on Directors and Corporate Governance ... Director Compensation Table shows $371,675 total compensation. |
2025-03-26 | Julia A. Haller, M.D. Chair of the Science & Technology Committee Director Since: 2019 Age: 70 Board Committees • Science & Technology Committee (Chair) • Committee on Directors and Corporate Governance |
Data sourced from SEC filings. Last updated: 2025-07-01